CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Delisting notice
- 4 Grant or award Chief Executive Officer acquired 7,939 shares (grant or award)
- 4 Grant or award Exec VP Finance, CFO acquired 7,787 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Delisting notice
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at an average $0.90 ($3,582)
- 4 Open-market buy Director bought 7,000 shares at $0.88 ($6,167)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Exec VP Finance, CFO acquired 9,563 shares (grant or award)
Page 14 of 38 · 744 filings